C21 Investments INC 20-F annual reports

C21 Investments reports fiscal 2026 revenue growth driven by its expanded Nevada retail footprint while navigating complex U.S. federal cannabis regulations.

C21 Investments Inc. reported a 6.5% increase in FY2025 revenues to $30.1 million, driven by the acquisition and opening of a third retail dispensary in South Reno, Nevada, while navigating a higher net loss and significant federal cannabis tax challenges.

C21 Investments Inc. amends its transition report to explicitly identify columnar headings and footnote disclosures for the two months ended March 31, 2024.

C21 Investments Inc. files a transition report on Form 20-F/A to reflect its change in fiscal year-end from January 31 to March 31.

C21 Investments Inc. files its Form 20-F, highlighting strategic growth initiatives including a new dispensary acquisition and provides financial results for the two-month period ended March 31, 2024.

C21 Investments Inc. announces its fiscal year 2024 financial results, showcasing strategic initiatives and expansion in the Nevada cannabis market.